Humankind Investments LLC Purchases New Holdings in iShares Biotechnology ETF (NASDAQ:IBB)

Humankind Investments LLC acquired a new position in iShares Biotechnology ETF (NASDAQ:IBB – Free Report) in the fourth quarter, according to the company in its most recent filing with the SEC. The firm acquired 4,500 shares of the financial services provider’s stock, valued at approximately $611,000. A number of other hedge funds also recently modified […]

Related Keywords

,Nasdaq ,Nasdaq Biotechnology Index Fund ,Aptus Capital Advisors ,Huntington National Bank ,Pathstone Family Office ,Humankind Investments ,Capital Investment Advisors ,Shares Biotechnology ,Free Report ,Wealth Management ,Family Office ,National Bank ,Capital Advisors ,Prime Capital Investment Advisors ,Shares Nasdaq Biotechnology ,Shares Nasdaq Biotechnology Index Fund ,Industry Classification Benchmark ,